FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1149152001: Trilaciclib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4554214018 Trilaciclib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4554215017 Trilaciclib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trilaciclib (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Trilaciclib (substance) Is a Protein kinase inhibitor true Inferred relationship Some
Trilaciclib (substance) Is a Enzyme inhibitor false Inferred relationship Some
Trilaciclib (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein kinase inhibitor (disposition) true Inferred relationship Some
Trilaciclib (substance) Is a Pyrrole true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Trilaciclib dihydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Trilaciclib (substance) Inferred relationship Some
Trilaciclib only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib (substance) Inferred relationship Some 1
Product containing trilaciclib in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib (substance) Inferred relationship Some 1
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Trilaciclib (substance) Inferred relationship Some 1
Trilaciclib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib (substance) Inferred relationship Some 1
Product containing only trilaciclib in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Trilaciclib (substance) Inferred relationship Some 1
Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Trilaciclib (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start